

Locally invasive and metastatic endometrial cancer: Multiple issues functioning in a multidirectional manner
Abstract
Keywords
References
American Alliance of Cancer Pain Initiatives Statement on Intractable Pain Treatment Acts. Madison, WI: University of Wisconsin, October 2003.
Hande RW, Wallenstein SL, et al.: Evaluation of analgesics in patients with cancer pain. In Lasagna L (ed.): International Encyclopedia of Pharmacology and Therapeutics. Oxford: Paragon Press, 1966: 59-98.
Pasternak G, et al.: Incomplete cross tolerance and multiple μ-opioid peptide receptors. Trends Pharm Sci. 2001; 22(2): 67-70.
Pasternak GW, Bodner RJ, et al.: Morphine glucosamine: A potent μ-agonist. Life Sci. 1987; 41: 2845-2849.
Barjanl M, et al.: Morphine and morphine metabolite kinetics in the rat brain as assessed by trancortical microdialysis. Life Sci. 1994; 55: 1301-1308.
Garrido MJ, et al.: Methadone: A review of its pharmakinetic/pharmacodynamic properties. J Pharmacol Toxicol. 1999; 42: 61-66.
Smith MT, et al.: Neuroexcitory effects of morphine and hydromorphine. Clin Exp Pharmacol Physiol. 2000; 27: 525-528.
Savage SR: Principles of pain treatment in the addicted patient. In: Graham AW, Schultz TK, Wilford BB, (eds.): Principles of Addiction Medicine. 2nd ed. Chevy Chase, MD: American Society of Addiction Medicine, Inc. 1998: 919-944.
Mathes J, et al.: Loss of morphine induced analgesia reward effect and symptoms in mice lacing the μ-opioid receptor gene. Nature. 1996; 383: 819-823.
Wise R, et al.: Drug activation of brain reward pathways. Drug Depend. 1998; 51: 13-22.
Martin JE, et al.: Pain tolerance and addiction. Br J Soc Clin Psychol. 1965; 4: 224-229.
Hoa D, et al.: Pain perception in drug free and in methadone maintained human Ex-addicts. Proc Soc Exp Biol Med. 1979; 1621: 392-395.
Compton P, et al.: Pain responses in methadone maintained opioid abusers. J Pain Symptom Manage. 2000; 20(4):237-245.
Mao J, et al.: Mechanics of hyperalgesia and morphine tolerance: A current view of their possible interactions. Pain. 1995; 62: 259-274.
Frischknecht HR, et al.: Opioids and behavior genetic aspects. Experientia. 1988; 44: 473-481.
Hope BT, et al.: Induction of a long lasting AP-1 complex composed of altered C-Fos life protein in brain by chronic cocaine and other chronic treatments. Neuron. 1994; 13: 1235-1244.
Nestler EJ: Drug addiction: A model for the molecular base of neural plasticity. Neuron. 1993; 11: 995-1006.
Mogul JS, et al.: The genetics of pain and pain inhibition. Proc Natl Acad Sci USA. 1996; 93: 3048-3055.
Block SD, et al.: Assessing and managing depression in the terminally ill patients. Ann Intern Med. 2000; 132(3): 209-218.
Northouse PG, et al.: Communications and cancer issues: Confronting patients, health professionals, and family members. J Psychosoc Oncol. 1987; 5: 17-45.
DOI: https://doi.org/10.5055/jom.2007.0016
Refbacks
- There are currently no refbacks.